181 related articles for article (PubMed ID: 23522954)
61. In vivo antitumor and antimetastatic activity of sunitinib in preclinical neuroblastoma mouse model.
Zhang L; Smith KM; Chong AL; Stempak D; Yeger H; Marrano P; Thorner PS; Irwin MS; Kaplan DR; Baruchel S
Neoplasia; 2009 May; 11(5):426-35. PubMed ID: 19412427
[TBL] [Abstract][Full Text] [Related]
62. Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
Prenen H; Smeets D; Mazzone M; Lambrechts D; Sagaert X; Sciot R; Debiec-Rychter M
Oncotarget; 2015 Nov; 6(34):36418-25. PubMed ID: 26474454
[TBL] [Abstract][Full Text] [Related]
63. Yeast-derived beta-glucan augments the therapeutic efficacy mediated by anti-vascular endothelial growth factor monoclonal antibody in human carcinoma xenograft models.
Salvador C; Li B; Hansen R; Cramer DE; Kong M; Yan J
Clin Cancer Res; 2008 Feb; 14(4):1239-47. PubMed ID: 18281559
[TBL] [Abstract][Full Text] [Related]
64. Anti-tumor effect of bevacizumab on a xenograft model of feline mammary carcinoma.
Michishita M; Ohtsuka A; Nakahira R; Tajima T; Nakagawa T; Sasaki N; Arai T; Takahashi K
J Vet Med Sci; 2016 May; 78(4):685-9. PubMed ID: 26616000
[TBL] [Abstract][Full Text] [Related]
65. Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth.
Sanches Jde S; de Aguiar RB; Parise CB; Suzuki JM; Chammas R; de Moraes JZ
Cancer Sci; 2016 Apr; 107(4):551-5. PubMed ID: 27079440
[TBL] [Abstract][Full Text] [Related]
66. Combined VEGFR and MAPK pathway inhibition in angiosarcoma.
Wagner MJ; Lyons YA; Siedel JH; Dood R; Nagaraja AS; Haemmerle M; Mangala LS; Chanana P; Lazar AJ; Wang WL; Ravi V; Holland EC; Sood AK
Sci Rep; 2021 Apr; 11(1):9362. PubMed ID: 33931674
[TBL] [Abstract][Full Text] [Related]
67. The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models.
Liu J; Deng GH; Zhang J; Wang Y; Xia XY; Luo XM; Deng YT; He SS; Mao YY; Peng XC; Wei YQ; Jiang Y
Psychoneuroendocrinology; 2015 Feb; 52():130-42. PubMed ID: 25437118
[TBL] [Abstract][Full Text] [Related]
68. Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report.
Yang L; Liu L; Han B; Han W; Zhao M
BMC Cancer; 2018 May; 18(1):618. PubMed ID: 29855279
[TBL] [Abstract][Full Text] [Related]
69. Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models.
Tahir SA; Kurosaka S; Tanimoto R; Goltsov AA; Park S; Thompson TC
Cancer Biol Ther; 2013 Feb; 14(2):117-26. PubMed ID: 23114714
[TBL] [Abstract][Full Text] [Related]
70. Metabolic impact of anti-angiogenic agents on U87 glioma cells.
Mesti T; Savarin P; Triba MN; Le Moyec L; Ocvirk J; Banissi C; Carpentier AF
PLoS One; 2014; 9(6):e99198. PubMed ID: 24922514
[TBL] [Abstract][Full Text] [Related]
71. Antitumor effect of bevacizumab in a xenograft model of canine hemangiopericytoma.
Michishita M; Uto T; Nakazawa R; Yoshimura H; Ogihara K; Naya Y; Tajima T; Azakami D; Kishikawa S; Arai T; Takahashi K
J Pharmacol Sci; 2013; 121(4):339-42. PubMed ID: 23514785
[TBL] [Abstract][Full Text] [Related]
72. Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to Pazopanib.
Ravi V; Sanford EM; Wang WL; Ross JS; Ramesh N; Futreal A; Patel S; Stephens PJ; Miller VA; Ali SM
J Natl Compr Canc Netw; 2016 May; 14(5):499-502. PubMed ID: 27160228
[TBL] [Abstract][Full Text] [Related]
73. Targeting angiogenesis as a promising modality for the treatment of prostate cancer.
Lin J; Kelly WK
Urol Clin North Am; 2012 Nov; 39(4):547-60. PubMed ID: 23084530
[TBL] [Abstract][Full Text] [Related]
74. Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.
Wentink MQ; Hackeng TM; Tabruyn SP; Puijk WC; Schwamborn K; Altschuh D; Meloen RH; Schuurman T; Griffioen AW; Timmerman P
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12532-12537. PubMed ID: 27791128
[TBL] [Abstract][Full Text] [Related]
75. Combination of bevacizumab and irradiation on uveal melanoma: an in vitro and in vivo preclinical study.
Sudaka A; Susini A; Lo Nigro C; Fischel JL; Toussan N; Formento P; Tonissi F; Lattanzio L; Russi E; Etienne-Grimaldi MC; Merlano M; Milano G
Invest New Drugs; 2013 Feb; 31(1):59-65. PubMed ID: 22714791
[TBL] [Abstract][Full Text] [Related]
76. Antiangiogenic agents: fueling cancer's hypoxic roots.
Conley SJ; Wicha MS
Cell Cycle; 2012 Apr; 11(7):1265-6. PubMed ID: 22421155
[No Abstract] [Full Text] [Related]
77. Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study.
Torok S; Vegvari A; Rezeli M; Fehniger TE; Tovari J; Paku S; Laszlo V; Hegedus B; Rozsas A; Dome B; Marko-Varga G
Br J Pharmacol; 2015 Feb; 172(4):1148-63. PubMed ID: 25363319
[TBL] [Abstract][Full Text] [Related]
78. Nintedanib and a bi-specific anti-VEGF/Ang2 nanobody selectively prevent brain metastases of lung adenocarcinoma cells.
Kovalchuk B; Berghoff AS; Karreman MA; Frey K; Piechutta M; Fischer M; Grosch J; Heiland S; Breckwoldt MO; Hilberg F; Wick W; Winkler F
Clin Exp Metastasis; 2020 Dec; 37(6):637-648. PubMed ID: 32918638
[TBL] [Abstract][Full Text] [Related]
79. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.
Garcia D; Nasarre P; Bonilla IV; Hilliard E; Peterson YK; Spruill L; Broome AM; Hill EG; Yustein JT; Mehrotra S; Klauber-DeMore N
Ann Surg Oncol; 2019 Dec; 26(13):4782-4790. PubMed ID: 31515721
[TBL] [Abstract][Full Text] [Related]
80. Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
Bannoud N; Stupirski JC; Cagnoni AJ; Hockl PF; Pérez Sáez JM; García PA; Mahmoud YD; Gambarte Tudela J; Scheidegger MA; Marshall A; Corrie PG; Middleton MR; Mariño KV; Girotti MR; Croci DO; Rabinovich GA
Proc Natl Acad Sci U S A; 2023 Jan; 120(3):e2214350120. PubMed ID: 36634146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
